⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KOD News
Kodiak Sciences Inc Common Stock
Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results
prnewswire.com
KOD
Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI)
prnewswire.com
KOD
New data for Kodiak's KSI-101 from the APEX study reinforce its clinically meaningful vision gains and rapid retinal drying in macular edema secondary to inflammation (MESI)
prnewswire.com
KOD
KOD